Paratek Pharmaceuticals Investor Relations Material

Paratek Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for infectious diseases. The company specializes in antibiotics that address serious bacterial infections, including drug-resistant strains. Paratek's products are designed to provide effective treatment options for conditions such as skin infections and community-acquired bacterial pneumonia. The company is headquartered in Boston, Massachusetts, and its shares are listed on the NASDAQ.